glucagon has been researched along with anandamide in 1 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (anandamide) | Trials (anandamide) | Recent Studies (post-2010) (anandamide) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 2,566 | 29 | 957 |
| Protein | Taxonomy | glucagon (IC50) | anandamide (IC50) |
|---|---|---|---|
| Fatty-acid amide hydrolase 1 | Homo sapiens (human) | 3.75 | |
| Potassium channel subfamily K member 3 | Homo sapiens (human) | 3 | |
| Potassium channel subfamily K member 2 | Bos taurus (cattle) | 1 | |
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | 4.78 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bermúdez-Silva, FJ; Nadal, A; Rodríguez de Fonseca, F; Suárez Pérez, J | 1 |
1 review(s) available for glucagon and anandamide
| Article | Year |
|---|---|
The role of the pancreatic endocannabinoid system in glucose metabolism.
Topics: Amides; Animals; Arachidonic Acids; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Diabetes Mellitus, Type 2; Endocannabinoids; Ethanolamines; Glucagon; Glucose; Glycerides; Homeostasis; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2009 |